List of Tables
Table 1. Cytotoxic Drug Market Trends
Table 2. Cytotoxic Drug Market Drivers & Opportunity
Table 3. Cytotoxic Drug Market Challenges
Table 4. Cytotoxic Drug Market Restraints
Table 5. Global Cytotoxic Drug Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Cytotoxic Drug Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Cytotoxic Drug Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Cytotoxic Drug Product Type
Table 9. Key Companies Time to Begin Mass Production of Cytotoxic Drug
Table 10. Global Cytotoxic Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytotoxic Drug as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Cytotoxic Drug Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Cytotoxic Drug Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Cytotoxic Drug Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Cytotoxic Drug Sales Market Share in Value by Type (2020-2025)
Table 17. Global Cytotoxic Drug Sales Market Share in Value by Type (2026-2031)
Table 18. Global Cytotoxic Drug Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Cytotoxic Drug Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Cytotoxic Drug Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Cytotoxic Drug Sales Market Share in Value by Application (2020-2025)
Table 22. Global Cytotoxic Drug Sales Market Share in Value by Application (2026-2031)
Table 23. Global Cytotoxic Drug Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Cytotoxic Drug Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Cytotoxic Drug Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Cytotoxic Drug Sales Value by Region (2020-2025) & (%)
Table 27. Global Cytotoxic Drug Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Cytotoxic Drug Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Cytotoxic Drug Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Cytotoxic Drug Sales Value, (2026-2031) & (US$ Million)
Table 31. Roche Basic Information List
Table 32. Roche Description and Business Overview
Table 33. Roche Cytotoxic Drug Products, Services and Solutions
Table 34. Revenue (US$ Million) in Cytotoxic Drug Business of Roche (2020-2025)
Table 35. Roche Recent Developments
Table 36. Eli Lilly Basic Information List
Table 37. Eli Lilly Description and Business Overview
Table 38. Eli Lilly Cytotoxic Drug Products, Services and Solutions
Table 39. Revenue (US$ Million) in Cytotoxic Drug Business of Eli Lilly (2020-2025)
Table 40. Eli Lilly Recent Developments
Table 41. Celgene Basic Information List
Table 42. Celgene Description and Business Overview
Table 43. Celgene Cytotoxic Drug Products, Services and Solutions
Table 44. Revenue (US$ Million) in Cytotoxic Drug Business of Celgene (2020-2025)
Table 45. Celgene Recent Developments
Table 46. Sanofi Basic Information List
Table 47. Sanofi Description and Business Overview
Table 48. Sanofi Cytotoxic Drug Products, Services and Solutions
Table 49. Revenue (US$ Million) in Cytotoxic Drug Business of Sanofi (2020-2025)
Table 50. Sanofi Recent Developments
Table 51. eisai Basic Information List
Table 52. eisai Description and Business Overview
Table 53. eisai Cytotoxic Drug Products, Services and Solutions
Table 54. Revenue (US$ Million) in Cytotoxic Drug Business of eisai (2020-2025)
Table 55. eisai Recent Developments
Table 56. Sumitomo Dainippon Pharma Basic Information List
Table 57. Sumitomo Dainippon Pharma Description and Business Overview
Table 58. Sumitomo Dainippon Pharma Cytotoxic Drug Products, Services and Solutions
Table 59. Revenue (US$ Million) in Cytotoxic Drug Business of Sumitomo Dainippon Pharma (2020-2025)
Table 60. Sumitomo Dainippon Pharma Recent Developments
Table 61. Merck Basic Information List
Table 62. Merck Description and Business Overview
Table 63. Merck Cytotoxic Drug Products, Services and Solutions
Table 64. Revenue (US$ Million) in Cytotoxic Drug Business of Merck (2020-2025)
Table 65. Merck Recent Developments
Table 66. Seattle Genetics Basic Information List
Table 67. Seattle Genetics Description and Business Overview
Table 68. Seattle Genetics Cytotoxic Drug Products, Services and Solutions
Table 69. Revenue (US$ Million) in Cytotoxic Drug Business of Seattle Genetics (2020-2025)
Table 70. Seattle Genetics Recent Developments
Table 71. Takeda Basic Information List
Table 72. Takeda Description and Business Overview
Table 73. Takeda Cytotoxic Drug Products, Services and Solutions
Table 74. Revenue (US$ Million) in Cytotoxic Drug Business of Takeda (2020-2025)
Table 75. Takeda Recent Developments
Table 76. Haosoh Pharma Basic Information List
Table 77. Haosoh Pharma Description and Business Overview
Table 78. Haosoh Pharma Cytotoxic Drug Products, Services and Solutions
Table 79. Revenue (US$ Million) in Cytotoxic Drug Business of Haosoh Pharma (2020-2025)
Table 80. Haosoh Pharma Recent Developments
Table 81. Novartis Basic Information List
Table 82. Novartis Description and Business Overview
Table 83. Novartis Cytotoxic Drug Products, Services and Solutions
Table 84. Revenue (US$ Million) in Cytotoxic Drug Business of Novartis (2020-2025)
Table 85. Novartis Recent Developments
Table 86. AstraZeneca Basic Information List
Table 87. AstraZeneca Description and Business Overview
Table 88. AstraZeneca Cytotoxic Drug Products, Services and Solutions
Table 89. Revenue (US$ Million) in Cytotoxic Drug Business of AstraZeneca (2020-2025)
Table 90. AstraZeneca Recent Developments
Table 91. Jazz Pharma Basic Information List
Table 92. Jazz Pharma Description and Business Overview
Table 93. Jazz Pharma Cytotoxic Drug Products, Services and Solutions
Table 94. Revenue (US$ Million) in Cytotoxic Drug Business of Jazz Pharma (2020-2025)
Table 95. Jazz Pharma Recent Developments
Table 96. Spectrum Pharma Basic Information List
Table 97. Spectrum Pharma Description and Business Overview
Table 98. Spectrum Pharma Cytotoxic Drug Products, Services and Solutions
Table 99. Revenue (US$ Million) in Cytotoxic Drug Business of Spectrum Pharma (2020-2025)
Table 100. Spectrum Pharma Recent Developments
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. Cytotoxic Drug Downstream Customers
Table 104. Cytotoxic Drug Distributors List
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Cytotoxic Drug Product Picture
Figure 2. Global Cytotoxic Drug Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Cytotoxic Drug Sales Value (2020-2031) & (US$ Million)
Figure 4. Cytotoxic Drug Report Years Considered
Figure 5. Global Cytotoxic Drug Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Cytotoxic Drug Revenue in 2024
Figure 7. Cytotoxic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Injection Picture
Figure 9. Solid Oral Dose Forms Picture
Figure 10. Others Picture
Figure 11. Global Cytotoxic Drug Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Cytotoxic Drug Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Breast Cancer
Figure 14. Product Picture of Blood Cancer
Figure 15. Product Picture of Prostate Cancer
Figure 16. Product Picture of Respiratory/Lung Cancer
Figure 17. Product Picture of Other
Figure 18. Global Cytotoxic Drug Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 19. Global Cytotoxic Drug Sales Value Market Share by Application, 2024 & 2031
Figure 20. North America Cytotoxic Drug Sales Value (2020-2031) & (US$ Million)
Figure 21. North America Cytotoxic Drug Sales Value by Country (%), 2024 VS 2031
Figure 22. Europe Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 23. Europe Cytotoxic Drug Sales Value by Country (%), 2024 VS 2031
Figure 24. Asia Pacific Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 25. Asia Pacific Cytotoxic Drug Sales Value by Region (%), 2024 VS 2031
Figure 26. South America Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 27. South America Cytotoxic Drug Sales Value by Country (%), 2024 VS 2031
Figure 28. Middle East & Africa Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 29. Middle East & Africa Cytotoxic Drug Sales Value by Country (%), 2024 VS 2031
Figure 30. Key Countries/Regions Cytotoxic Drug Sales Value (%), (2020-2031)
Figure 31. United States Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 32. United States Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 33. United States Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 34. Europe Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 35. Europe Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 36. Europe Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 37. China Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 38. China Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 39. China Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 40. Japan Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 41. Japan Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 42. Japan Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 43. South Korea Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 44. South Korea Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 45. South Korea Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 46. Southeast Asia Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 48. Southeast Asia Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 49. India Cytotoxic Drug Sales Value, (2020-2031) & (US$ Million)
Figure 50. India Cytotoxic Drug Sales Value by Type (%), 2024 VS 2031
Figure 51. India Cytotoxic Drug Sales Value by Application (%), 2024 VS 2031
Figure 52. Cytotoxic Drug Industrial Chain
Figure 53. Cytotoxic Drug Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
